| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Shares issued for sepa | 2,039,195 | - |
| Shares issued for cash | 3,024,633 | - |
| Warrants issued for cash | 650 | 500 |
| Preferred stock offering | 5,455,000 | 5,455,000 |
| Net cash provided by financing activities | 11,290,728 | 6,226,750 |
| Net increase (decrease) in cash | 4,375,602 | 1,463,841 |
| Cash and cash equivalents at beginning of period | 532,885 | - |
| Cash and cash equivalents at end of period | 4,908,487 | - |
Coeptis Therapeutics Holdings, Inc. (COEPW)
Coeptis Therapeutics Holdings, Inc. (COEPW)